Skip to main content
FinSpry Logo
FinSpry
ALT logo
ALT
(NASDAQ)
Altimmune, Inc.
$3.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Altimmune (ALT) Stock Price & Financial Analysis

Altimmune Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.07 - $3.35
52-Week High$7.73
52-Week Low$2.87
Open$3.10
Volume2.73M
Average Volume (3M)2.73M
Market Cap294.27M
Shares Outstanding88.10M
Price to Sales (P/S)6704.51
Price to Book (P/B)1.22
EV/EBITDA-2.98
Revenue (TTM)41.00K
Net Income (TTM)-88.09M
Free Cash Flow (TTM)-67.55M
EPS (TTM)$-0.88
Profit Margin-214860.98%
Operating Margin-230460.98%
Return on Equity (ROE)-39.17%
Debt to Equity0.16
50-Day MA$4.27
200-Day MA$4.24
52-Week Change-34.25%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 6, 2017

Frequently Asked Questions About Altimmune

What is the current stock price for ALT?

As of the latest trading session, ALT stock trades at $3.34. The 52-week range is $2.87–$7.73, with a day range of $3.07–$3.35.

What is the P/E ratio for ALT?

The P/E ratio (Price-to-Earnings) for ALT is shown in the Key Statistics section. This valuation metric helps compare Altimmune, Inc. to industry peers.

Does ALT pay dividends?

Altimmune does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALT?

Based on 5 analysts, the consensus for ALT is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALT?

Altimmune's market capitalization is $294.3M, classifying it as a micro-cap company. Altimmune operates in the Healthcare sector within the Biotechnology industry.